For Mounjaro, across the SURPASS trials in type 2 diabetes, cholelithiasis was reported in 0.6% of tirzepatide-treated patients compared to 0% in the placebo group
Atherosclerosis as an infectious, inflammatory and autoimmune disease
The research is still early, but here is what we know: GIP and thyroid hormone release: GIP has been shown to stimulate the release of calcitonin from thyroid C-cells in animal models
The effect of one-carbon components supplementation during early gestation on fetal jejunum morphology was recently evaluated (Daneshi et al., 2025)
Howard et al., Science, 1996 Ipamorelin identity Study topic: the first description of Ipamorelin as a selective growth-hormone secretagogue
It is important to appropriately generalize this information to groups of patients that fit the populations in these studies